Literature DB >> 6347476

Affinity of myeloma IgG proteins for fibronectin.

A Hautanen, J Keski-Oja.   

Abstract

The ability of purified human myeloma IgG proteins to interact with human plasma fibronectin was studied by enzyme immunoassays. Seven of eight different myeloma IgG proteins representing all four IgG subclasses bound to solid phase fibronectin in a dose-dependent manner. The binding of myeloma IgG to solid phase fibronectin could be inhibited by soluble fibronectin and gelatin, but not by heparin or bovine serum albumin. Evidence for an antigen-antibody type interaction was not observed by double diffusion analysis. Affinity chromatography of radiolabelled cell culture medium over IgG-Sepharose showed that only fibronectin bound to the IgG-conjugates. The affinity of IgG molecules for fibronectin may play a role in cryoimmunoglobulinaemia associated with certain pathological states.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347476      PMCID: PMC1535551     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

2.  Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen.

Authors:  A Vaheri; M Kurkinen; V P Lehto; E Linder; R Timpl
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 3.  Activation of the complement system by antibody-antigen complexes: the classical pathway.

Authors:  R R Porter; K B Reid
Journal:  Adv Protein Chem       Date:  1979

Review 4.  Cryoimmunoglobulins.

Authors:  H M Grey; P F Kohler
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Interaction of fibronectin with C1q and its collagen-like fragment (CLF).

Authors:  E J Menzel; J S Smolen; L Liotta; K B Reid
Journal:  FEBS Lett       Date:  1981-06-29       Impact factor: 4.124

7.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

8.  The binding of human complement component C4 to antibody-antigen aggregates.

Authors:  R D Campbell; A W Dodds; R R Porter
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

9.  Specific effects of fibronectin-releasing peptides on the extracellular matrices of cultured human fibroblasts.

Authors:  J Keski-Oja; G J Todaro
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

10.  Interaction of plasma fibronectin with selected cryoglobulins.

Authors:  G Wood; M Rucker; J W Davis; R Entwistle; B Anderson
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

View more
  9 in total

1.  The role of fibronectin in the cryoprecipitation of monoclonal cryoglobulins.

Authors:  J Strevey; A D Beaulieu; C Ménard; J P Valet; L Latulippe; J Hébert
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

2.  Affinity of fibronectin for polyclonal IgG.

Authors:  M Salvarrey; A Rostagno
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

Authors:  J S Coppock; D L Scott; S D Carter; T M Moreland; M W Robinson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

4.  Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation.

Authors:  D L Scott; M W Robinson; S Yoshino
Journal:  Br J Exp Pathol       Date:  1985-10

5.  Diagnostic relevance of fibronectin in cryoprecipitates.

Authors:  M W Robinson; K W Walton; D G Scott; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.

Authors:  S E Carsons; S Schwartzman; H S Diamond; E Berkowitz
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

7.  Plasma fibronectin and microvascular damage in essential mixed cryoglobulinaemia.

Authors:  V Toschi; P Renoldi; A Motta; C Cimminiello; G Arpaia; G F Fiorini
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

8.  Fibronectin and immune complexes in rheumatic diseases.

Authors:  K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; D L Scott
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

9.  Differences between plasma and synovial fluid fibronectin.

Authors:  D L Scott; S D Carter; J S Coppock; M Robinson; K W Walton
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.